Shengxu Li1, Ruth J F Loos. 1. Medical Research Council Epidemiology Unit, Institute of Metabolic Science, Cambridge, UK.
Abstract
PURPOSE OF REVIEW: Over the past two decades serious efforts has been invested in the search for genes that predispose to common obesity, but progress has been slow and success limited. Genome-wide association, however, has revived optimism. Here we review recent advances in the field of obesity genetics and discuss the most important findings of candidate gene, genome-wide linkage studies and genome-wide association studies. We conclude by speculating about the way forward in the near future. RECENT FINDINGS: Although large-scale candidate gene studies have placed MC4R more firmly on the human obesity map, the major breakthrough in obesity genetics was the discovery of FTO through genome-wide association. Variants located in the first intron of FTO were unequivocally associated with a 1.67-fold increased risk for obesity and a 0.40-0.66 kg/m2 increase in body mass index. SUMMARY: Genome-wide association promises to enhance greatly our understanding of the genetic basis of common obesity, although candidate gene studies will remain a valuable approach because they allow more detailed analyses of biologically relevant candidates. A key factor contributing to continued success lies in large-scale data integration through international collaboration, which will provide the sample sizes required to identify genetic association with conclusive evidence.
PURPOSE OF REVIEW: Over the past two decades serious efforts has been invested in the search for genes that predispose to common obesity, but progress has been slow and success limited. Genome-wide association, however, has revived optimism. Here we review recent advances in the field of obesity genetics and discuss the most important findings of candidate gene, genome-wide linkage studies and genome-wide association studies. We conclude by speculating about the way forward in the near future. RECENT FINDINGS: Although large-scale candidate gene studies have placed MC4R more firmly on the humanobesity map, the major breakthrough in obesity genetics was the discovery of FTO through genome-wide association. Variants located in the first intron of FTO were unequivocally associated with a 1.67-fold increased risk for obesity and a 0.40-0.66 kg/m2 increase in body mass index. SUMMARY: Genome-wide association promises to enhance greatly our understanding of the genetic basis of common obesity, although candidate gene studies will remain a valuable approach because they allow more detailed analyses of biologically relevant candidates. A key factor contributing to continued success lies in large-scale data integration through international collaboration, which will provide the sample sizes required to identify genetic association with conclusive evidence.
Authors: Mohamed T Hassanein; Helen N Lyon; Thutrang T Nguyen; Ermeg L Akylbekova; Kevin Waters; Guillaume Lettre; Bamidele Tayo; Terrence Forrester; Daniel F Sarpong; Dan O Stram; Johannah L Butler; Rainford Wilks; Jiankang Liu; Loic Le Marchand; Laurence N Kolonel; Xiaofeng Zhu; Brian Henderson; Richard Cooper; Colin McKenzie; Herman A Taylor; Christopher A Haiman; Joel N Hirschhorn Journal: Hum Mol Genet Date: 2010-04-29 Impact factor: 6.150
Authors: Kimberly R Coenen; Sharon M Karp; Sabina B Gesell; Mary S Dietrich; Thomas M Morgan; Shari L Barkin Journal: Clin Transl Sci Date: 2011-10 Impact factor: 4.689
Authors: Chao-Qiang Lai; Laurence D Parnell; Donna K Arnett; Bibiana García-Bailo; Michael Y Tsai; Edmond K Kabagambe; Robert J Straka; Michael A Province; Ping An; Ingrid B Borecki; Katherine L Tucker; José M Ordovás Journal: Obesity (Silver Spring) Date: 2008-12-18 Impact factor: 5.002
Authors: Paul Welsh; Eliana Polisecki; Michele Robertson; Sabine Jahn; Brendan M Buckley; Anton J M de Craen; Ian Ford; J Wouter Jukema; Peter W Macfarlane; Chris J Packard; David J Stott; Rudi G J Westendorp; James Shepherd; Aroon D Hingorani; George Davey Smith; Ernst Schaefer; Naveed Sattar Journal: J Clin Endocrinol Metab Date: 2009-11-11 Impact factor: 5.958
Authors: Elizabeth M Azzato; Lindsay M Morton; Andrew W Bergen; Sophia S Wang; Nilanjan Chatterjee; Paul Kvale; Meredith Yeager; Richard B Hayes; Stephen J Chanock; Neil E Caporaso Journal: BMC Med Genet Date: 2009-01-30 Impact factor: 2.103